View Older Stories View More Recent Stories
-
Marvel Biosciences extends private placement deadline to Sept. 14
-
Marvel Biosciences Announces Extension to Closing Date of Private Placement
-
Citi says this chipmaker is "the key beneficiary of the CPU renaissance"
-
After an 18% summer selloff in chip stocks, Citi asks what comes next
-
Earnings dip in this chip stock creates buying opportunity ahead of Investor Day: analyst
-
Marvel Biosciences Announces Grant of Deferred Share Units
-
Active options: MRVL PLTR SOFI GOOGL AMD SMCI CRM MARA HOOD
-
Marvell (MRVL) PT Raised to $325 at Oppenheimer
-
Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
-
Popular stocks: MRVL IREN SPCX INTC MU MSTR CRM PLTR PYPL MARA GAP SOFI AMD
-
Benchmark Reiterates Buy Rating on Marvell (MRVL) Following Earnings
-
Marvell (MRVL) Stock: Risk/Reward Skewed to the Upside Near-Term Following Selloff, Says Analyst
-
KeyBanc on Marvell (MRVL): 'Strong Results and Guide from DC Strength'
-
Marvell (MRVL) PT Raised to $300 at Needham
-
Marvell (MRVL) Reiterated at Buy by Stifel on July Quarter Beat
-
Marvell (MRVL) Reiterated at Buy by UBS After Modest Beat and Raise Results
-
Marvell (MRVL) PT Raised to $280 at Wolfe Research
-
Stocks expected to have increasing option volume: MRVL WDAY PD GAP IREN S AFRM ULTA RBRK ADSK FOX FOXA MRNA ESI SOLS
-
Marvell (MRVL) PT Raised to $246 at Morgan Stanley
-
After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
-
Goldman Sachs on Marvell (MRVL): 'We expect the stock to be range bound following results that were in line'
-
Marvell Technology (MRVL) Tops Q2 EPS by 1c, Offers Guidance
-
Marvell earnings preview: Is a beat-and-raise quarter possible?
-
Marvell Technology (MRVL) August 28 weekly 245 straddle priced into quarter results
-
Marvell Technology (MRVL) call put ratio 1.6 calls to 1 put into quarter results
-
Marvell (MRVL) PT Raised to $265 at Susquehanna
-
Rosenblatt Assumes Marvell (MRVL) at Buy
-
Benchmark Reiterates Buy Rating on Marvell (MRVL) Ahead of Q2 Results
-
BMO Capital Starts Marvell (MRVL) at Outperform
-
Oppenheimer Reiterates Outperform Rating on Marvell (MRVL) Amid Google Deal
-
Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
-
Marvell (MRVL) PT Raised to $310 at UBS
-
Barclays Reiterates Overweight Rating on Marvell (MRVL)
-
JPMorgan Reiterates Overweight Rating on Marvell (MRVL)
-
JPMorgan Reiterates Overweight Rating on Marvell (MRVL)
-
Marvell signs major custom silicon deal with Google, sell-side comments
-
Raymond James Reiterates Strong Buy Rating on Marvell (MRVL) following custom silicon/warrant deal with Google
-
Marvell shares jump after giving Google warrants amid custom chip deal
-
Marvell issues Google warrant tied to custom chip deal
-
Marvell (MRVL) PT Raised to $225 at TD Cowen
-
Marvell (MRVL) Reiterated at Buy by Stifel on Expected Q2 Beat
-
Active options: MRVL MSTR SNDK PLTR NBIS EYPT GOOGL RUN ONDS
-
Marvell (MRVL) PT Raised to $195 at Goldman Sachs
-
Marvell unveils new AI memory infrastructure products at FMS 2026
-
Marvell plans $250M India investment, to double headcount
-
Chip stocks extend global rebound following last week's rout
-
Erste Group Downgrades Marvell (MRVL) to Hold
-
UBS raises Marvell and Astera estimates on CXL opportunity
-
Intel (INTC) PT Raised to $150 at Cantor Fitzgerald: Outperforming in Accelerator Market
-
Marvell Technology (MRVL) Declares $0.06 Quarterly Dividend; 0.1% Yield
